GPB Passport icon GPB Passport icon Passport
GPB donate icon GPB donate icon Donate
Sign Up For Our Newsletter

News Articles: GenBioPro

The drug manufacturer GenBioPro received FDA approval for its generic version of the abortion pill mifepristone — the first dose in a widely-used, two-drug protocol — in 2019.

Generic abortion pill manufacturer sues FDA in effort to preserve access

GenBioPro, which makes a generic form of mifepristone, is suing the FDA seeking to preserve access to the drug amidst ongoing federal litigation.

|
By:
  • Sarah McCammon